Tagged as: Biosimilars News

Express Scripts and Walgreens Expand Their Group Purchasing to Include Biosimilars

Express Scripts and Walgreens Boots Alliance announced this week that “they are expanding their group purchasing efforts to include the procurement of specialty brand drugs,” including biosimilars.  According to Tim Wentworth, Express Scripts President and CEO, “[s]pecialty medications represent the most costly and complex drugs.  By expanding our efforts with Walgreens Boots Alliance, we…

Read More

American College of Rheumatology White Paper Encourages Use of Biosimilars

Last week, the American College of Rheumatology (ACR) published a new white paper “encourag[ing] providers to incorporate [biosimilars] into the treatment plans of patients with rheumatic diseases where appropriate.” The paper, titled “The Science Behind Biosimilars — Entering a New Era of Biologic Therapy,” discusses the regulatory regime for biosimilars,…

Read More